A likely pathogenic variant putatively affecting splicing of PIGA identified in a multiple congenital anomalies hypotonia‐seizures syndrome 2 (MCAHS2) family pedigree via whole‐exome sequencing. Issue 5 (4th July 2018)

• Record Type: Journal Article
• Authors: Yang, Junli; Wang, Qiong; Zhuo, Qingcui; Tian, Huiling; Li, Wen; Luo, Fang; Zhang, Jinghui; Bi, Dan; Peng, Jing; Zhou, Dong; Xin, Huawei
• Is Part Of: Molecular genetics & genomic medicine. Volume 6:Issue 5(2018)
• Page Start: 739
• Page End: 748
• Publication Date: 2018-07-04
• Subjects: glycosylphosphatidylinositol -- GPI -- IGD -- inherited GPI deficiency -- MCAHS2 -- multiple congenital anomalies hypotonia‐seizures syndrome 2 -- phosphatidylinositol glycan anchor biosynthesis class A -- PIGA -- PIGA deficiency -- splicing defect -- WES -- whole‐exome sequencing; Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.428
• Languages: English
• ISSNs: 2324-9269

Abstract

Abstract: Background: Glycosylphosphatidylinositol (GPI) anchoring is a special type of protein posttranslational modification, by which proteins with diverse function are attached to cell membrane through a covalent linkage between the protein and the glycolipid. Phosphatidylinositol glycan anchor biosynthesis class A (PIGA) is a key enzyme in GPI anchor biosynthesis, somatic mutations or genetic variants of which have been associated with paroxysmal nocturnal hemoglobinuria (PNH), or PIGA deficiency, respectively. More than 10 PIGA pathogenic or likely pathogenic variants have been reported in a wide spectrum of clinical syndromes of PIGA deficiency, including multiple congenital anomalies hypotonia‐seizures syndrome 2 (MCAHS2). Methods: Whole‐exome sequencing (WES) was performed on two trios, that is., the proband's family and his affected maternal cousin's family, from a nonconsanguineous Chinese family pedigree with hypotonia‐encephalopathy‐seizures disease history and putative X‐linked recessive inheritance. Sanger sequencing for PIGA variant was performed on affected members as well as unaffected members in the family pedigree to verify its familial segregation. Results: A novel likely pathogenic variant in PIGA was identified through comparative WES analysis of the two affected families. The single‐nucleotide substitution (NC_000023.9:g.15343279T>C) is located in intron 3 of the PIGA gene and within the splice acceptor consensus sequence (NM_002641.3:c.849‐5A>G). Even though we have not performed RNA studies, in silico tools predict that this intronic variant may alter normal splicing, causing a four base pair insertion which creates a frameshift and a premature stop codon at position 297 (NP_002632.1:p.(Arg283Serfs*15)). Sanger sequencing analysis of the extended family members confirmed the presence of the variant and its X‐linked inheritance. Conclusion: WES data analysis along with familial segregation of a rare intronic variant are suggestive of a diagnosis of X‐liked PIGA deficiency with clinical features of MCAHS2. Abstract : Glycosylphosphatidylinositol (GPI) anchoring is a special type of protein posttranslational modification. Phosphatidylinositol glycan anchor biosynthesis class A (PIGA) is a key enzyme in GPI anchor biosynthesis, somatic mutations or genetic variants of which have been associated with paroxysmal nocturnal hemoglobinuria (PNH), or PIGA deficiency, respectively. In this study we reported the patient information and genetic analysis result of a nonconsanguineous Chinese family pedigree with disease history of multiple congenital anomalies hypotonia‐seizures syndrome 2 (MCAHS2) (one form of PIGA deficiency), that is, a novel likely pathogenic variant in PIGA with putative splicing defect was identified by comparative whole‐exome sequencing analysis and confirmed by Sanger sequencing of extended family pedigree members, as well as in silico splice site prediction analysis.